Bayer gets Ultravist FDA approval for contrast-enhanced mammography
Bayer has received US Food and Drug Administration (FDA) approval for Ultravist (iopromide) injection, its iodine-based contrast agent, to be used for contrast-enhanced mammography (CEM). This marks Ultravist as the sole contrast agent approved for this purpose. The product will be employed to enhance visualization of known or suspected breast lesions in adult patients, complementing […]